GlobalData completed it's acquisition of CBR Pharma in January 2019, all studies released since this date are listed under: GlobalData
CBR Pharma Insights reports are designed to empower readers to make better strategic decisions by providing incisive and timely analyses of key R&D, corporate, legislative and commercial issues and events shaping the industry and are prepared by a network of domain-specialists, analysts and ex-industry professionals.
CBR Pharma Insights features:
- Analyses include KOL opinion to provide more intuitive insights
- Rapid reaction to breaking issues and events that will shape the pharma industry
- Agile research approach to ensure each report project is assigned to the most appropriate analyst
- Consulting-style PowerPoint slide deck format - nothing but value-added content
Driven by key industry events & trends, i.e.:
- Regulatory Reform
- Strategies for Generics and Biosimilars
- New and Emerging Marketing Strategies
- Lifecycle Management
- The Payer Environment and Reimbursement
See and search within all CBR Pharma studies from the past 24 months